Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid in treatment of acute tramadol poisoning
IRCT2017050120951N3Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- May 2017
- Modality
- Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of Intralipid 10% in tramadol overdose, sponsored by Qazvin University of Medical Sciences. Started May 2017; status: completed.
02
Drugs
Intralipid 10%
03
Conditions
tramadol overdose
Beyond the preview
Go deeper on IRCT2017050120951N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017050120951N3.